Year: 2026
Type: preprint
Abstract: Arteriovenous malformations (AVMs) are high-flow vascular anomalies defined by direct artery-to-vein shunts, often resulting in hemodynamic instability, vessel rupture, and life-threatening hemorrhage. Causative mutations in ENG, ALK1, and SMAD4 are well-established in hereditary hemorrhagic telangiectasia (HHT), yet AVM severity varies widely among individuals carrying the same mutation, implicating host-specific modifiers that remain poorly defined. Here we test whether collateral vessel density modifies AVM severity in vivo. Using Rabep2-knockout mice, which have reduced collateral vessel density, we examined AVM severity in two independent AVM mouse models (Eng-and Alk1-inducible knockouts). Rabep2 deletion significantly reduced the number of pial and dorsal skin collaterals; this was accompanied by attenuated AVM formation, with smaller lesion volume and preserved hemoglobin levels. Collateral number correlated positively AVM severity at the individual animal level. In a retinal AVM model lacking native collaterals, Rabep2 deletion did not alter AVM formation, indicating that this effect requires a collateral network. These results identify collateral vessel density as a physiological modulator of AVM severity and suggest that vascular architecture and hemodynamics, rather than genetic signaling alone, shape AVM outcome.
Source: Research Square
Institutions: Barrow Neurological Institute, Duke University
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
Award: G8910394555
OpenAlex ID: W7236439139
